Entity
Description
  • Value proposition

    Combining human and machine intelligence to accelerate the discovery of advanced medicines.

    LabGenius is the first biopharmaceutical company developing next generation protein therapeutics using a machine learning-driven evolution engine (EVATM).

    Our protein engineering platform integrates several bleeding edge technologies
    from the fields of machine learning, synthetic biology and robotics.

    Synthetic Biology, Protein Engineering, Artificial Intelligence, Machine Learning, High Throughput Screening, Medical, Health, DNA Libraries, drug discovery, and protein therapeutics

  • LabGenius | ML-driven Antibody Discovery

    At LabGenius, we're finding the next generation of antibody therapeutics with machine learning, synthetic biology and laboratory automation

  • https://labgeni.us/
Corporate interactions BETA
Corporate TypeTweets Articles
Apple
Apple
Consumer Electronics, Computers and Electronics Manufacturing
Apple
Consumer Electronics, Computers and Electronics Manufacturing
Other

21 Jan 2024


AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

31 Aug 2023


UK Atomic Energy Authority
UK Atomic Energy Authority
Research, National and local authorities
UK Atomic Energy Authority
Research, National and local authorities
Other

31 Dec 2023


CogX Festival
CogX Festival
Software Development
CogX Festival
Software Development
Not capitalistic
Not partnership
Event

1 Oct 2023


Sanofi
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Not capitalistic
Partnership
Not event

24 Sep 2023


Sifted
Sifted
Newspaper Publishing
Sifted
Newspaper Publishing
Not capitalistic
Not partnership
Event

31 Aug 2023


Similar entities
Loading...
Loading...
Social network dynamics